Legionella pneumophila

Last updated

Legionella pneumophila
Legionella pneumophila (SEM).jpg
Colorized scanning electron micrograph image of L. pneumophila
Scientific classification OOjs UI icon edit-ltr.svg
Domain: Bacteria
Phylum: Pseudomonadota
Class: Gammaproteobacteria
Order: Legionellales
Family: Legionellaceae
Genus: Legionella
Species:
L. pneumophila
Binomial name
Legionella pneumophila
Brenner DJ, Steigerwalt AG, McDade JE 1979

Legionella pneumophila, the primary causative agent for Legionnaire's disease, is an aerobic, pleomorphic, flagellated, non-spore-forming, Gram-negative bacterium. [1] [2] L. pneumophila is a intracellular parasite that preferentially infects soil amoebae and freshwater protozoa for replication. [3] [4] Due to L. pneumophila’s ability to thrive in water, it can grow in water filtration systems, leading to faucets, showers, and other fixtures. Aerosolized water droplets containing L. pneumophila originating from these fixtures may be inhaled by humans. [5] Upon entry to the human respiratory tract, L. pneumophila is able to infect and reproduce within human alveolar macrophages. [4] This causes the onset of Legionnaires' disease, also known as legionellosis. [4] Infected humans may display symptoms such as fever, delirium, diarrhea, and decreased liver and kidney function. [6] L. pneumophila infections can be diagnosed by a urine antigen test. [7] [8] The infections caused by the bacteria can be treated with fluoroquinolones and azithromycin antibiotics. [7]

Contents

Characterization

L. pneumophila is a coccobacillus. [9] It is a Gram-negative, aerobic bacterium that is non-fermentative. It is oxidase- and catalase-positive. [10] L. pneumophila colony morphology is gray-white with a textured, cut-glass appearance; it also requires cysteine and iron to thrive. [11] It grows on buffered charcoal yeast extract agar as well as in moist environments, such as tap water, in "opal-like" colonies. [11]

L. pneumophila is a intracellular bacterium. As an intracellular parasite, L. pneumophila has a preferential parasitic relationship with protozoa, which serve as a reservoir for the bacterium. [12] Predators of protozoa, such as amoeba and ciliates, are natural hosts for L. pneumophila while humans are accidental hosts, as evidenced by there being only one reported case of L. pneumophila human-to-human transmission. Rather than through contagious spread, it infects the alveolar macrophages in human lungs when inhaled as aerosol. [13] [14]

A special characteristic allows for the microbe to thrive in extracellular environments, such as various freshwater environments. This is achieved through its two forms: transmissive and replicative. The transition between the two is activated by changes in the availability of metabolic/nutritional resources in its current environment. The transmissive form is assumed when the bacteria is infecting its host, while the replicative form follows to carry out proliferation. [14]

Cell membrane structure

L. pneumophila is a Gram-negative bacterium. Its unique outer membrane composed of lipoproteins, phospholipids, and other proteins is the distinguishing feature of Legionella spp. Legionella spp. possess unique lipopolysaccharides (LPS) extending from the outer membrane leaflet of the outer cell membrane that play a role in pathogenicity and adhesion to a host cell. Lipopolysaccharides are the leading surface antigen of all Legionella species including L. pneumophila. [15]

The bases for the somatic antigen specificity of this organism are located on the side chains of its cell wall. The chemical composition of these LPS side chains both with respect to components and arrangement of the different sugars, determines the nature of the somatic or O-antigenic determinants, which are important means of serologically classifying many Gram-negative bacteria. L. pneumophila exhibits distinct chemical characteristics in its LPS structure that distinguish it from other Gram-negative bacteria. [16] The unique attributes are key factors in its serological identity and biological function. [16]

Ecology

L. pneumophila (red chains) multiplying inside Tetrahymena pyriformis T. pyriformis hosting L. pneumophila.png
L. pneumophila (red chains) multiplying inside Tetrahymena pyriformis

L. pneumophila is able to live in a diverse range of environmental conditions, tolerating temperatures from 0°C-63 °C, a pH range of 5.0-8.5, and in dissolved oxygen concentrations of 0.2-15.0 mg/liter. However, it multiplies within a narrower temperature range of 25 °C to 42 °C. [17]

L. pneumophila is notably resistant to chlorine derivatives that are commonly used to control water borne pathogens. This resistance allows infiltration and persistence in water systems even when standard disinfectant processes are employed. [5] Water supply networks are the main source of L. pneumophila contamination, with the microbe commonly found in places such as cooling towers, water systems of hospitals, hotels, and cruise ships. [18] Of note, this bacterium can form and reside in biofilms within water system pipes, allowing it be aerosolized through fixtures such as faucets, showers, and sprinklers. Exposure to these aerosols can lead to infection in susceptible individuals. [19]

Biofilms

Biofilms are specialized, surface attachment communities that can consist of one or multiple microbes, ranging from bacteria, algae, and protozoa. [17] These protective matrixes enable the microbe to live for extended periods of time in low-nutrient environments and in the presence of biocides. [10] Multispecies biofilm on plumbing systems and in water distribution systems facilitate L. pneumophila growth due to the presence of freshwater protozoa. [17] [20]

Environmental Protozoa

L. pneumophila is capable of infecting and multiplying within various species of free-living protists and amoebas. This bacterium can infect and survive within protozoa genera such as Acanthamoeba, Vermamoeba, and Naegleria which often feed on bacteria in biofilms. [12] [5] It is through their growth in environmental protozoa and amoeba that L. pneumophila may persist in man-made water systems. Cyst-forming protozoans allow L. pneumophila to survive harsh environmental conditions such as chlorine, UV, ozonisation, and thermal treatments. [21]

Metabolism

L. pneumophila uses glycolysis, the Entner-Doudoroff (ED) pathway, the pentose phosphate pathway (PP), and the citric acid cycle (TCA). While its genome contains genes for all these pathways, it lacks the genes encoding for the key enzymes type I–III fructose 1,6-bisphosphatases in gluconeogenesis. L. pneumophila can still perform gluconeogenesis, but uses alternative enzymes such as fructose 6-phosphate aldolase. The ED and PP pathways are the main pathways for glucose metabolism in this organism. [22] Glucose is not the main source of energy, but does generate poly-3-hydroxybutyrate (PHB) through the ED pathway, which is a storage molecule converted to acetyl-CoA for use by the TCA cycle (Krebs cycle) when the microbe is nutrient deprived. [23] Along with these pathways, serine was found to be a major nutrient due to its ability to be turned into pyruvate, which is an important intermediate in metabolic pathways in L. pneumophila. Glycerol is also used as a substrate, as indicated by transcriptome analysis. [22]

While carbohydrates and complex polysaccharides are minimally metabolized, amino acids are the main carbon and energy source for L. pneumophila. [24] Imported amino acids are used by L. pneumophila to generate energy through the TCA cycle (Krebs cycle) and as sources of carbon and nitrogen. [23]

Nutrient acquisition

Legionella is auxotrophic for seven amino acids: cysteine, leucine, methionine, valine, threonine, isoleucine, and arginine. Inside the vacuole, nutrient availability is low; the high demand of amino acids is not covered by the transport of free amino acids found in the host cytoplasm. To improve the availability of amino acids, the parasite promotes the host mechanisms of proteasomal degradation. This generates an excess of free amino acids in the cytoplasm of L. pneumophila-infected cells that can be used for intravacuolar proliferation of the parasite. Amino acids are imported into the LCV through various amino acid transporters such as the neutral amino acid transporter B(0). [25] Even though L. pneumophila primarily uses amino acids as a carbon source, the bacteria does contain multiple amylases, such as LamB which hydrolyzes polysaccharides into glucose monomers for metabolism. [23]

Protein degradation to recycle amino acids and hydrolyzing polysaccharides are not the only methods by which L. pneumophila obtains carbon and energy sources from the host. Type II–secreted degradative enzymes may provide an additional strategy to generate carbon and energy sources. L. pneumophila is the only known intracellular pathogen to have a Type II Secretion System (secretome). [26] [27]

Genomics

There are 14 known serogroups of L. pneumophila, but serogroup 1 is most commonly the causative agent of Legionnaires’ disease. [28] Three strains, L. pneumophila Philadelphia, L. pneumophila Paris, and L. pneumophila Lens, were isolated in 2004 which paved the way for understanding the molecular biology of the bacteria. Subspecies, which are commonly defined by geographical location, share about 80% of their genome with variation between strains that account for the difference in virulence between subspecies. The genome is relatively large of about 3.5 mega base pairs (mbp) which reflects a higher number of genes, corresponding with the ability of Legionella to adapt to different hosts and environments. There is a relatively high abundance genes encoding eukaryotic-like proteins (ELPs). ELPs are beneficial for mimicking the bacteria' eukaryotic hosts for pathogenicity. Other genes of L. pneumophila encode for Legionella-specific vacuoles, efflux transporters, ankyrin-repeat proteins, and many other virulence related characteristics. [29] The bffA gene is associated with biofilm formation, and it is seen that strains without this gene form biofilms both quicker and thicker which aids in resistance to environmental stressors. [30] In-depth comparative genome analysis using DNA arrays to study the gene content of 180 Legionella strains revealed high genomic plasticity and frequent horizontal gene transfer events. [29] Horizontal gene transfer allows L. pneumophila to evolve at a rapid pace and commonly is associated with drug resistance. [31]

Pathogenesis

The life cycle of L. pneumophila within a amoeba. The life cycle of Legionella pneumophila within eukaryotic host cells.jpg
The life cycle of L. pneumophila within a amoeba.
Image of alveoli filled with leukocytes and fibrin due to pneumonia caused by Legionella bacteria. Legionella pneumonia (3785990105).jpg
Image of alveoli filled with leukocytes and fibrin due to pneumonia caused by Legionella bacteria.

L. pneumophila is able to invade and replicate within human alveolar macrophages. Internalization of the bacteria appears to occur through phagocytosis or coiling phagocytosis and is reliant on Dot/Icm type 4B secretion system (T4BSS). Once internalized, the Dot/Icm system begins secreting bacterial effector proteins that recruit host factors to the Legionella containing vacuole (LCV). This process prevents the LCV from fusing with the lysosomes that would otherwise degrade the bacteria. Vesicles of the host cell's rough endoplasmic reticulum are attracted to the LCV, and these vacuoles supple the LCV with necessary lipids and proteins. [13] LCV membrane integrity requires a steady supply of host lipids, such as cellular cholesterol and the cis-monounsaturated fatty acid, palmitoleic acid. [33] [34] L. pneumophila replication occurs within the LCV. Once nutrients are depleted, the bacteria gain flagella and cytoxicity. To exit the host cell, L. pneumophila lyses the LCV and resides in the cytoplasm. In the cytoplasm, L. pneumophila inhibit organelle and plasma membrane function and structure which ultimately leads to osmotic lysis of the host cell. [35]

Virulence factors

L. pneumophila exhibits a unique lipopolysaccharide (LPS) structure that is highly hydrophobic due to its being densely packed with branched fatty acids, and elevated levels of O-acetyl and N-acetyl groups. This structure helps prevent interaction with a common LPS immune system co-receptor, CD14. There is also a correlation between an LPS with a high molecular-weight and the inhibition of phagosome-lysosome fusion. [36] L. pneumophila produces pili of varying lengths. The two pili proteins: PilE and Prepilin peptidase (PilD) are responsible for the production of type IV pili and subsequently, intracellular proliferation. [37] L. pneumophila possesses a singular, polar flagellum that is used for cell motility, adhesion, host invasion, and biofilm formation. The same regulators that control flagellation also control lysosome avoidance and cytotoxicity. [36] The macrophage infectivity potentiator is another key component of host cell invasion and intracellular replication. MIP displays peptidyl–prolyl cis/trans isomerase (PPIase) activity which is crucial for survival within the macrophage, along with transmigration across the lung epithelial barrier. [36] [37]

Another key virulence factor of L. pneumophila is iron acquisition, the microbe utilizes two methods of iron uptake. Ferrous iron is collected through the use of a transport system involving an inner-membrane protein known as protein FeoB. Optimal intracellular infection is achieved in amoebae and macrophages via this transport system. The second form of uptake, involving ferric iron, is achieved through an iron chelator known as legiobactin. This is secreted by L. pneumophila when the microbes are being grown in a low iron chemically designed media. [38]

Legionella-containing vacuole

TEM image of L. pneumophila within a phagocytic cell TEM image of Legionella pneumophila within a phagocytic cell.tif
TEM image of L. pneumophila within a phagocytic cell

For Legionella to survive within macrophages and protozoa, it must create a specialized compartment known as the Legionella-containing vacuole (LCV). [39] Through the action of the Dot/Icm secretion system, the bacteria are able to prevent degradation by the normal endosomal trafficking pathway and instead replicate. Shortly after internalization, the bacteria specifically recruit endoplasmic reticulum-derived vesicles and mitochondria to the LCV while preventing the recruitment of endosomal markers such as Rab5a and Rab7a. Formation and maintenance of the vacuoles are crucial for pathogenesis; bacteria lacking the Dot/Icm secretion system are not pathogenic and cannot replicate within cells, while deletion of the Dot/Icm effector SdhA results in destabilization of the vacuolar membrane and no bacterial replication. [40] [41]

Detection and treatment

Antisera have been used both for slide agglutination studies and for direct detection of bacteria in tissues using immunofluorescence via fluorescent-labelled antibodies. Specific antibodies in patients can be determined by the indirect fluorescent antibody test. ELISA and microagglutination tests have also been successfully applied. [8] A consistent method that has been used to detect the disease is the urine antigen test. [7]

Effective antibiotic treatment for Legionella pneumonia includes fluoroquinolones (levofloxacin or moxifloxacin) or, alternately, azithromycin. There has been no significant difference found between using a fluoroquinolone or azithromycin to treat Legionella pneumonia. Combination treatments with rifampicin are being tested as a response to antibiotic resistance during mono-treatments, though its effectiveness remains uncertain. [7]

These antibiotics work best because L. pneumophila is an intracellular pathogen. [42] Levofloxacin and azithromycin have great intracellular activity and are able to penetrate into Legionella-infected cells. The Infectious Diseases Society of America recommends 5–10 days of treatment with levofloxacin or 3–5 days of treatment with azithromycin; however, patients that are immunocompromised or have a severe disease may require an extended course of treatment. [42] Enzymes in the iron uptake pathway have been also suggested as important drug targets. [38]

Prevalence

L. pneumophila is the primary causative organism for Legionnaires disease, responsible for over 90% of cases within the United States. [43] Roughly 2 out of 100,000 people are infected each year in the European Union (EU), with an infection rate of approximately 5 per 100,000 in Italy. [44] The highest reported amount of cases in the US, EU, and Italy have been among men over the age of 50. [44] [43] L. pneumophila often infects individuals through poor quality water sources. Approximately 20% of reported Legionnaires disease cases come from healthcare, senior living, or travel facilities that have been exposed to water contaminated with L. pneumophila. [43] There may also be an increased risk of contracting L. pneumophila from private wells, as they are often unregulated and not as rigorously disinfected as municipal water systems. [45] Several large outbreaks of Legionnaire's Disease have come from public hot tubs due to the temperature range of the water being ideal for the bacteria's growth. [46] [47]

Legionnaires disease gained globally recognition after an outbreak in 1976 at a hotel in Philadelphia, Pennsylvania. The causative agent of the outbreak was L. pneumophila, which had contaminated the hotel's air conditioning water supply, allowing the microbe to be dispersed within the hotel's environment. A prominent mode of transmission for the disease is the inhalation of contaminated water aerosols. [43] The outbreak resulted in a total of 182 reported cases and 29 deaths. [44] This incident piloted research on the disease causing bacteria, as well as, preventative approaches to contamination. [43]

More recently, two outbreaks of Legionnaires disease among travelers on two cruise ships between November 2022 and June 2024 were reported by the United States Centers for Disease Control and Prevention (CDC). Hot tubs were identified as the likely source and the cruise lines modified their operation by increasing frequency of cleaning and hyperchlorination among other changes. [48]

Related Research Articles

<i>Legionella</i> Pathogenic genus of gram-negative bacteria and the related disease

Legionella is a genus of gram-negative bacteria that can be seen using a silver stain or grown in a special media that contains cysteine, an amino acid. It is known to cause legionellosis including a pneumonia-type illness called Legionnaires' disease and a mild flu-like illness called Pontiac fever. These bacteria are common in many places, like soil and water. There are over 50 species and 70 types (serogroups) identified. Legionella does not spread from person-to-person. Most individuals who are exposed to the bacteria do not get sick. Most outbreaks result from poorly maintained cooling towers.

<i>Listeria monocytogenes</i> Species of pathogenic bacteria that causes the infection listeriosis

Listeria monocytogenes is the species of pathogenic bacteria that causes the infection listeriosis. It is a facultative anaerobic bacterium, capable of surviving in the presence or absence of oxygen. It can grow and reproduce inside the host's cells and is one of the most virulent foodborne pathogens. Twenty to thirty percent of foodborne listeriosis infections in high-risk individuals may be fatal. In the European Union, listeriosis continues an upward trend that began in 2008, causing 2,161 confirmed cases and 210 reported deaths in 2014, 16% more than in 2013. In the EU, listeriosis mortality rates also are higher than those of other foodborne pathogens. Responsible for an estimated 1,600 illnesses and 260 deaths in the United States annually, listeriosis ranks third in total number of deaths among foodborne bacterial pathogens, with fatality rates exceeding even Salmonella spp. and Clostridium botulinum.

<i>Rickettsia rickettsii</i> Species of bacterium

Rickettsia rickettsii is a Gram-negative, intracellular, cocco-bacillus bacterium that was first discovered in 1902. Having a reduced genome, the bacterium harvests nutrients from its host cell to carry out respiration, making it an organo-heterotroph. Maintenance of its genome is carried out through vertical gene transfer where specialization of the bacterium allows it to shuttle host sugars directly into its TCA cycle.

<i>Coxiella burnetii</i> Species of bacterium

Coxiella burnetii is an obligate intracellular bacterial pathogen, and is the causative agent of Q fever. The genus Coxiella is morphologically similar to Rickettsia, but with a variety of genetic and physiological differences. C. burnetii is a small Gram-negative, coccobacillary bacterium that is highly resistant to environmental stresses such as high temperature, osmotic pressure, and ultraviolet light. These characteristics are attributed to a small cell variant form of the organism that is part of a biphasic developmental cycle, including a more metabolically and replicatively active large cell variant form. It can survive standard disinfectants, and is resistant to many other environmental changes like those presented in the phagolysosome.

Legionella longbeachae is one species of the family Legionellaceae. It was first isolated from a patient in Long Beach, California. It is found predominantly in potting soil and compost. Human infection from L. longbeachae is particularly common in Australia, but cases have been documented in other countries including the United States, Japan, Greece and the UK.

<i>Francisella tularensis</i> Species of bacterium

Francisella tularensis is a pathogenic species of Gram-negative coccobacillus, an aerobic bacterium. It is nonspore-forming, nonmotile, and the causative agent of tularemia, the pneumonic form of which is often lethal without treatment. It is a fastidious, facultative intracellular bacterium, which requires cysteine for growth. Due to its low infectious dose, ease of spread by aerosol, and high virulence, F. tularensis is classified as a Tier 1 Select Agent by the U.S. government, along with other potential agents of bioterrorism such as Yersinia pestis, Bacillus anthracis, and Ebola virus. When found in nature, Francisella tularensis can survive for several weeks at low temperatures in animal carcasses, soil, and water. In the laboratory, F. tularensis appears as small rods, and is grown best at 35–37 °C.

<span class="mw-page-title-main">Phagosome</span> Vesicle formed around a particle engulfed by a phagocyte via phagocytosis

In cell biology, a phagosome is a vesicle formed around a particle engulfed by a phagocyte via phagocytosis. Professional phagocytes include macrophages, neutrophils, and dendritic cells (DCs).

<i>Brucella suis</i> Bacterium that causes swine brucellosis

Brucella suis is a bacterium that causes swine brucellosis, a zoonosis that affects pigs. The disease typically causes chronic inflammatory lesions in the reproductive organs of susceptible animals or orchitis, and may even affect joints and other organs. The most common symptom is abortion in pregnant susceptible sows at any stage of gestation. Other manifestations are temporary or permanent sterility, lameness, posterior paralysis, spondylitis, and abscess formation. It is transmitted mainly by ingestion of infected tissues or fluids, semen during breeding, and suckling infected animals.

Intracellular parasites are microparasites that are capable of growing and reproducing inside the cells of a host. They are also called intracellular pathogens.

Host tropism is the infection specificity of certain pathogens to particular hosts and host tissues. This explains why most pathogens are only capable of infecting a limited range of host organisms.

<span class="mw-page-title-main">EEA1</span> Protein-coding gene in humans

The gene EEA1 encodes for the 1400 amino acid protein, Early Endosome Antigen 1.

<i>Rhodococcus equi</i> Species of bacterium

Rhodococcus equi is a Gram-positive coccobacillus bacterium. The organism is commonly found in dry and dusty soil and can be important for diseases of domesticated animals. The frequency of infection can reach near 60%. R. equi is an important pathogen causing pneumonia in foals. Since 2008, R. equi has been known to infect wild boar and domestic pigs. R. equi can infect immunocompromised people, such as HIV-AIDS patients or organ transplant recipients. Rhodococcus equi infection in these populations resemble the clinical and pathological signs of advanced pulmonary tuberculosis. This organism is a facultative intracellular mycobacterial pathogen.

AnkB F-Box is a protein excreted by Legionella pneumophila which contains a domain F-box.

Legionella cherrii is an aerobic, flagellated, Gram-negative bacterium from the genus Legionella. It was isolated from a heated water sample in Minnesota. L. cherrii is similar to another Legionella species, L. pneumophila, and is believed to cause major respiratory problems.

Legionella jordanis is a Gram-negative bacterium from the genus Legionella which was isolated from the Jordan River in Bloomington, Indiana and from the sewage in DeKalb County, Georgia. L. jordanis is a rare human pathogen and can cause respiratory tract infections.

<span class="mw-page-title-main">Legionnaires' disease</span> Form of atypical pneumonia

Legionnaires' disease is a form of atypical pneumonia caused by any species of Legionella bacteria, quite often Legionella pneumophila. Signs and symptoms include cough, shortness of breath, high fever, muscle pains, and headaches. Nausea, vomiting, and diarrhea may also occur. This often begins 2–10 days after exposure.

Legionella clemsonensis was isolated in 2006, but was described in 2016 by Clemson University researchers. It is a Gram-negative bacterium.

<span class="mw-page-title-main">Michele Swanson</span> American microbiologist

Michele S. Swanson is an American biologist who is a professor of microbiology at the University of Michigan. She has investigated the water-borne pathogen Legionella pneumophila. Swanson is interested in the metabolic cues that underpin the virulence of L. pneumophila and how it is transmitted to humans. She served as president of the American Society for Microbiology in 2018.

<span class="mw-page-title-main">Symbiosis in Amoebozoa</span>

Amoebozoa of the free living genus Acanthamoeba and the social amoeba genus Dictyostelium are single celled eukaryotic organisms that feed on bacteria, fungi, and algae through phagocytosis, with digestion occurring in phagolysosomes. Amoebozoa are present in most terrestrial ecosystems including soil and freshwater. Amoebozoa contain a vast array of symbionts that range from transient to permanent infections, confer a range of effects from mutualistic to pathogenic, and can act as environmental reservoirs for animal pathogenic bacteria. As single celled phagocytic organisms, amoebas simulate the function and environment of immune cells like macrophages, and as such their interactions with bacteria and other microbes are of great importance in understanding functions of the human immune system, as well as understanding how microbiomes can originate in eukaryotic organisms.

References

  1. ↑ Madigan M, Martinko J, eds. (2005). Brock Biology of Microorganisms (11th ed.). Prentice Hall. ISBN   0-13-144329-1.
  2. ↑ Heuner K, Swanson M, eds. (2008). Legionella: Molecular Microbiology. Caister Academic Press. ISBN   978-1-904455-26-4.
  3. ↑ Rowbotham TJ (December 1980). "Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae". Journal of Clinical Pathology. 33 (12): 1179–1183. doi:10.1136/jcp.33.12.1179. PMC   1146371 . PMID   7451664.
  4. 1 2 3 Winn Jr WC (1996). "Legionella". In Baron S (ed.). Medical Microbiology (4th ed.). University of Texas: The University of Texas Medical Branch at Galveston. ISBN   0-9631172-1-1. PMID   21413250.
  5. 1 2 3 Abdel-Nour M, Duncan C, Low DE, Guyard C (October 2013). "Biofilms: the stronghold of Legionella pneumophila". International Journal of Molecular Sciences. 14 (11): 21660–21675. doi: 10.3390/ijms141121660 . PMC   3856027 . PMID   24185913.
  6. ↑ Djordjevic Z, Folic M, Petrovic I, Zornic S, Stojkovic A, Miljanovic A, et al. (May 2022). "An outbreak of Legionnaires' disease in newborns in Serbia". Paediatrics and International Child Health. 42 (2): 59–66. doi:10.1080/20469047.2022.2108672. PMID   35944175. S2CID   251468797.
  7. 1 2 3 4 Viasus D, Gaia V, Manzur-Barbur C, Carratalà J (June 2022). "Legionnaires' Disease: Update on Diagnosis and Treatment". Infectious Diseases and Therapy. 11 (3): 973–986. doi:10.1007/s40121-022-00635-7. PMC   9124264 . PMID   35505000.
  8. 1 2 Conway de Macario E, Macario AJ, Wolin MJ (January 1982). "Specific antisera and immunological procedures for characterization of methanogenic bacteria". Journal of Bacteriology. 149 (1): 320–328. doi:10.1128/jb.149.1.320-328.1982. PMC   216625 . PMID   6172417.
  9. ↑ Gomez-Valero L, Rusniok C, Buchrieser C (September 2009). "Legionella pneumophila: population genetics, phylogeny and genomics". Infection, Genetics and Evolution. 9 (5): 727–739. Bibcode:2009InfGE...9..727G. doi:10.1016/j.meegid.2009.05.004. PMID   19450709.
  10. 1 2 Iliadi V, Staykova J, Iliadis S, Konstantinidou I, Sivykh P, Romanidou G, et al. (October 2022). "Legionella pneumophila: The Journey from the Environment to the Blood". Journal of Clinical Medicine. 11 (20): 6126. doi: 10.3390/jcm11206126 . PMC   9605555 . PMID   36294446.
  11. 1 2 Murdoch DR (January 2003). "Diagnosis of Legionella infection". Clinical Infectious Diseases. 36 (1): 64–69. doi: 10.1086/345529 . PMID   12491204.
  12. 1 2 Dey R, Mameri MR, Trajkovic-Bodennec S, Bodennec J, Pernin P (September 2020). "Impact of inter-amoebic phagocytosis on the L. pneumophila growth". FEMS Microbiology Letters. 367 (18). doi:10.1093/femsle/fnaa147. PMID   32860684.
  13. 1 2 Oliva G, Sahr T, Buchrieser C (2018-01-19). "The Life Cycle of L. pneumophila: Cellular Differentiation Is Linked to Virulence and Metabolism". Frontiers in Cellular and Infection Microbiology. 8: 3. doi: 10.3389/fcimb.2018.00003 . PMC   5780407 . PMID   29404281.
  14. 1 2 Fonseca MV, Swanson MS (2014). "Nutrient salvaging and metabolism by the intracellular pathogen Legionella pneumophila". Frontiers in Cellular and Infection Microbiology. 4: 12. doi: 10.3389/fcimb.2014.00012 . PMC   3920079 . PMID   24575391.
  15. ↑ Iliadi V, Staykova J, Iliadis S, Konstantinidou I, Sivykh P, Romanidou G, et al. (October 2022). "Legionella pneumophila: The Journey from the Environment to the Blood". Journal of Clinical Medicine. 11 (20): 6126. doi: 10.3390/jcm11206126 . PMC   9605555 . PMID   36294446.
  16. 1 2 Petzold M, Thürmer A, Menzel S, Mouton JW, Heuner K, Lück C (September 2013). "A structural comparison of lipopolysaccharide biosynthesis loci of Legionella pneumophila serogroup 1 strains". BMC Microbiology. 13 (1): 198. doi: 10.1186/1471-2180-13-198 . PMC   3766260 . PMID   24069939.
  17. 1 2 3 Uzel A, Hames-Kocabas EE (2010). Legionella Pneumophila: From Environment to Disease. NOVA Science Publishers. pp. 5–8. hdl:11454/19520. ISBN   978-1-60876-947-6.
  18. ↑ Yao XH, Shen F, Hao J, Huang L, Keng B (2024-07-26). "A review of Legionella transmission risk in built environments: sources, regulations, sampling, and detection". Frontiers in Public Health. 12. doi: 10.3389/fpubh.2024.1415157 . ISSN   2296-2565. PMC   11309999 . PMID   39131570.
  19. ↑ Hines SA, Chappie DJ, Lordo RA, Miller BD, Janke RJ, Lindquist HA, et al. (June 2014). "Assessment of relative potential for Legionella species or surrogates inhalation exposure from common water uses". Water Research. 56: 203–213. Bibcode:2014WatRe..56..203H. doi:10.1016/j.watres.2014.02.013. PMID   24681377.
  20. ↑ Abdel-Nour M, Duncan C, Low D, Guyard C (2013-10-31). "Biofilms: The Stronghold of Legionella pneumophila". International Journal of Molecular Sciences. 14 (11): 21660–21675. doi: 10.3390/ijms141121660 . ISSN   1422-0067. PMC   3856027 . PMID   24185913.
  21. ↑ Nisar MA, Ross KE, Brown MH, Bentham R, Whiley H (2020-04-15). "Legionella pneumophila and Protozoan Hosts: Implications for the Control of Hospital and Potable Water Systems". Pathogens. 9 (4): 286. doi: 10.3390/pathogens9040286 . ISSN   2076-0817. PMC   7238060 . PMID   32326561.
  22. 1 2 Eisenreich W, Heuner K (November 2016). "The life stage-specific pathometabolism of Legionella pneumophila". FEBS Letters. 590 (21): 3868–3886. doi: 10.1002/1873-3468.12326 . PMID   27455397. S2CID   8187321.
  23. 1 2 3 Best A, Price C, Ozanic M, Santic M, Jones S, Abu Kwaik Y (April 2018). "A Legionella pneumophila amylase is essential for intracellular replication in human macrophages and amoebae". Scientific Reports. 8 (1): 6340. Bibcode:2018NatSR...8.6340B. doi:10.1038/s41598-018-24724-1. PMC   5910436 . PMID   29679057.
  24. ↑ Manske C, Hilbi H (2014-09-09). "Metabolism of the vacuolar pathogen Legionella and implications for virulence". Frontiers in Cellular and Infection Microbiology. 4: 125. doi: 10.3389/fcimb.2014.00125 . ISSN   2235-2988. PMC   4158876 . PMID   25250244.
  25. ↑ Price CT, Richards AM, Abu Kwaik Y (2014-08-26). "Nutrient generation and retrieval from the host cell cytosol by intra-vacuolar Legionella pneumophila". Frontiers in Cellular and Infection Microbiology. 4: 111. doi: 10.3389/fcimb.2014.00111 . PMC   4143614 . PMID   25207263.
  26. ↑ Mintz CS (December 1999). "Gene transfer in Legionella pneumophila". Microbes and Infection. 1 (14): 1203–1209. doi:10.1016/s1286-4579(99)00241-5. PMID   10580276.
  27. ↑ DebRoy S, Dao J, Söderberg M, Rossier O, Cianciotto NP (2006-12-12). "Legionella pneumophila type II secretome reveals unique exoproteins and a chitinase that promotes bacterial persistence in the lung". Proceedings of the National Academy of Sciences. 103 (50): 19146–19151. Bibcode:2006PNAS..10319146D. doi: 10.1073/pnas.0608279103 . ISSN   0027-8424. PMC   1748190 . PMID   17148602.
  28. ↑ Ditommaso S, Giacomuzzi M, Rivera SR, Raso R, Ferrero P, Zotti CM (September 2014). "Virulence of Legionella pneumophila strains isolated from hospital water system and healthcare-associated Legionnaires' disease in Northern Italy between 2004 and 2009". BMC Infectious Diseases. 14 (1): 483. doi: 10.1186/1471-2334-14-483 . PMC   4168204 . PMID   25190206.
  29. 1 2 Steinert M, Heuner K, Buchrieser C, Albert-Weissenberger C, Glöckner G (November 2007). "Legionella pathogenicity: genome structure, regulatory networks and the host cell response". International Journal of Medical Microbiology. Special issue: Pathogenomics. 297 (7–8): 577–587. doi:10.1016/j.ijmm.2007.03.009. PMID   17467337.
  30. ↑ Marin C, Kumova OK, Ninio S (2022-01-27). "Characterization of a Novel Regulator of Biofilm Formation in the Pathogen Legionella pneumophila". Biomolecules. 12 (2): 225. doi: 10.3390/biom12020225 . ISSN   2218-273X. PMC   8961574 . PMID   35204726.
  31. ↑ Burmeister AR (July 2015). "Horizontal Gene Transfer". Evolution, Medicine, and Public Health. 2015 (1): 193–194. doi:10.1093/emph/eov018. PMC   4536854 . PMID   26224621.
  32. ↑ "Legionella pneumonia". Dr Yale Rosen Atlas of Pulmonary Pathology. 2009-08-01. Retrieved 2024-10-19– via www.flickr.com.
  33. ↑ Ondari E, Wilkins A, Latimer B, Dragoi AM, Ivanov SS (January 2023). "Cellular cholesterol licenses Legionella pneumophila intracellular replication in macrophages". Microbial Cell. 10 (1): 1–17. doi:10.15698/mic2023.01.789. PMC   9806796 . PMID   36636491.
  34. ↑ Wilkins AA, Schwarz B, Torres-Escobar A, Castore R, Landry L, Latimer B, et al. (2024). "The intracellular growth of the vacuolar pathogen Legionella pneumophila is dependent on the acyl chain composition of host membranes". Frontiers in Bacteriology. 3. bioRxiv   10.1101/2023.11.19.567753 . doi: 10.3389/fbrio.2024.1322138 .
  35. ↑ Newton HJ, Ang DK, van Driel IR, Hartland EL (April 2010). "Molecular pathogenesis of infections caused by Legionella pneumophila". Clinical Microbiology Reviews. 23 (2): 274–298. doi:10.1128/CMR.00052-09. PMC   2863363 . PMID   20375353.
  36. 1 2 3 Shevchuk O, Jäger J, Steinert M (2011). "Virulence properties of the legionella pneumophila cell envelope". Frontiers in Microbiology. 2: 74. doi: 10.3389/fmicb.2011.00074 . PMC   3129009 . PMID   21747794.
  37. 1 2 Talapko J, Frauenheim E, Juzbašić M, Tomas M, Matić S, Jukić M, et al. (January 2022). "Legionella pneumophila-Virulence Factors and the Possibility of Infection in Dental Practice". Microorganisms. 10 (2): 255. doi: 10.3390/microorganisms10020255 . PMC   8879694 . PMID   35208710.
  38. 1 2 Cianciotto NP (May 2015). "An update on iron acquisition by Legionella pneumophila: new pathways for siderophore uptake and ferric iron reduction". Future Microbiology. 10 (5): 841–851. doi:10.2217/fmb.15.21. PMC   4461365 . PMID   26000653.
  39. ↑ Isberg RR, O'Connor TJ, Heidtman M (January 2009). "The Legionella pneumophila replication vacuole: making a cosy niche inside host cells". Nature Reviews. Microbiology. 7 (1): 13–24. doi:10.1038/nrmicro1967. PMC   2631402 . PMID   19011659.
  40. ↑ Harding CR, Stoneham CA, Schuelein R, Newton H, Oates CV, Hartland EL, et al. (July 2013). "The Dot/Icm effector SdhA is necessary for virulence of Legionella pneumophila in Galleria mellonella and A/J mice". Infection and Immunity. 81 (7): 2598–2605. doi:10.1128/IAI.00296-13. PMC   3697626 . PMID   23649096.
  41. ↑ Creasey EA, Isberg RR (February 2012). "The protein SdhA maintains the integrity of the Legionella-containing vacuole". Proceedings of the National Academy of Sciences of the United States of America. 109 (9): 3481–3486. doi: 10.1073/pnas.1121286109 . PMC   3295292 . PMID   22308473.
  42. 1 2 Cunha BA, Burillo A, Bouza E (January 2016). "Legionnaires' disease". Lancet. 387 (10016): 376–385. doi:10.1016/s0140-6736(15)60078-2. PMID   26231463. S2CID   38821013.
  43. 1 2 3 4 5 Donohue MJ, Pham M, Brown S, Easwaran KM, Vesper S, Mistry JH (June 2023). "Water quality influences Legionella pneumophila determination". Water Research. 238: 119989. Bibcode:2023WatRe.23819989D. doi:10.1016/j.watres.2023.119989. PMC   10351031 . PMID   37137207.
  44. 1 2 3 Lupia T, Corcione S, Shbaklo N, Rizzello B, De Benedetto I, Concialdi E, et al. (February 2023). "Legionella pneumophila Infections during a 7-Year Retrospective Analysis (2016-2022): Epidemiological, Clinical Features and Outcomes in Patients with Legionnaires' Disease". Microorganisms. 11 (2): 498. doi: 10.3390/microorganisms11020498 . PMC   9965988 . PMID   36838463.
  45. ↑ Mapili K, Pieper KJ, Dai D, Pruden A, Edwards MA, Tang M, et al. (April 2020). "Legionella pneumophila occurrence in drinking water supplied by private wells". Letters in Applied Microbiology. 70 (4): 232–240. doi:10.1111/lam.13273. PMID   31904109. S2CID   209894300.
  46. ↑ Kuroki T, Amemura-Maekawa J, Ohya H, Furukawa I, Suzuki M, Masaoka T, et al. (February 2017). "Outbreak of Legionnaire's Disease Caused by Legionella pneumophila Serogroups 1 and 13". Emerging Infectious Diseases. 23 (2): 349–351. doi:10.3201/eid2302.161012. PMC   5324795 . PMID   28098535.
  47. ↑ Donovan CV, MacFarquhar JK, Wilson E, Sredl M, Tanz LJ, Mullendore J, et al. (March 2023). "Legionnaires' Disease Outbreak Associated With a Hot Tub Display at the North Carolina Mountain State Fair, September 2019". Public Health Reports. 139 (1): 79–87. doi:10.1177/00333549231159159. PMC  10905752. PMID   36971250. S2CID   257765345.
  48. ↑ Lee S (2024). "Two Outbreaks of Legionnaires Disease Associated with Outdoor Hot Tubs for Private Use — Two Cruise Ships, November 2022–July 2024". MMWR. Morbidity and Mortality Weekly Report. 73 (42): 950–954. doi:10.15585/mmwr.mm7342a3. ISSN   0149-2195. PMC   11500841 . PMID   39446669.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.